Hitting the snooze button for 30 minutes in the morning slightly improved or did not affect cognitive performance upon waking in habitual snoozers, according to research published in the Journal of Sleep Research.
Hitting the snooze button for 30 minutes in the morning slightly improved or did not affect cognitive performance upon waking in habitual snoozers, according to research published in the Journal of Sleep Research.
Just 3 months of home-based transcutaneous electrical stimulation improved obstructive sleep apnea (OSA) severity and sleepiness in patients with low adherence to continuous positive airway pressure (CPAP) therapy.
Just 3 months of home-based transcutaneous electrical stimulation improved obstructive sleep apnea (OSA) severity and sleepiness in patients with low adherence to continuous positive airway pressure (CPAP) therapy.
Better sleep consolidation and the absence of sleep apnea were associated with better global cognition over 5 years in an analysis of middle-aged to older US adults across five independent community-based cohorts.
Better sleep consolidation and the absence of sleep apnea were associated with better global cognition over 5 years in an analysis of middle-aged to older US adults across five independent community-based cohorts.
A study of veterans with alcohol use disorder found cognitive behavioral therapy outperformed sleep hygiene treatment in reducing insomnia, as well as alcohol consumption, cravings, and associated negative behaviors.
A study of veterans with alcohol use disorder found cognitive behavioral therapy outperformed sleep hygiene treatment in reducing insomnia, as well as alcohol consumption, cravings, and associated negative behaviors.
Having persistent distressing dreams in middle childhood was associated with an 85% increased risk of developing cognitive impairment or Parkinson disease by age 50 compared with never having distressing dreams.
Having persistent distressing dreams in middle childhood was associated with an 85% increased risk of developing cognitive impairment or Parkinson disease by age 50 compared with never having distressing dreams.
The medial temporal lobe (MTL) region of the brain may be especially vulnerable to reduced volume and other effects of sleep-disordered breathing (SDB), particularly in individuals with amyloid plaques.
The medial temporal lobe (MTL) region of the brain may be especially vulnerable to reduced volume and other effects of sleep-disordered breathing (SDB), particularly in individuals with amyloid plaques.
Insomnia is associated with higher use of antidepressants, particularly those with sedative effects, according to a poster presented at this week’s APA annual meeting.
Insomnia is associated with higher use of antidepressants, particularly those with sedative effects, according to a poster presented at this week’s APA annual meeting.
The US Food and Drug Administration (FDA) has recalled some sleep apnea machines manufactured by Philips Respironics for the second time, with this latest recall upgraded to Class I.
The US Food and Drug Administration (FDA) has recalled some sleep apnea machines manufactured by Philips Respironics for the second time, with this latest recall upgraded to Class I.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
Adolescents with higher levels of adiposity may be more susceptible to the cognitive effects of sleep restriction than those with lower adiposity, according to a recent single-blind randomized crossover trial.
Adolescents with higher levels of adiposity may be more susceptible to the cognitive effects of sleep restriction than those with lower adiposity, according to a recent single-blind randomized crossover trial.
Continuous positive airway pressure (CPAP) therapy is safe and effective in patients with obstructive sleep apnea (OSA) syndrome, according to study findings published in the journal Respiratory Physiology & Neurobiology.
Continuous positive airway pressure (CPAP) therapy is safe and effective in patients with obstructive sleep apnea (OSA) syndrome, according to study findings published in the journal Respiratory Physiology & Neurobiology.
The severity of obstructive sleep apnea (OSA) events during REM sleep is associated with worse verbal memory impairment in older adults at risk for Alzheimer disease (AD), according to a study published online in the journal Alzheimer’s...
The severity of obstructive sleep apnea (OSA) events during REM sleep is associated with worse verbal memory impairment in older adults at risk for Alzheimer disease (AD), according to a study published online in the journal Alzheimer’s...
Sleep apnea and low oxygen levels during sleep are associated with late-onset epilepsy independently of hypertension and stroke, according to a study published online in the journal Sleep.
Sleep apnea and low oxygen levels during sleep are associated with late-onset epilepsy independently of hypertension and stroke, according to a study published online in the journal Sleep.
Insomnia symptoms, even if mild, were found to be associated with increased drinking over time, according to findings from the “first study to examine if objective circadian measures can predict future alcohol use in adults.”
Insomnia symptoms, even if mild, were found to be associated with increased drinking over time, according to findings from the “first study to examine if objective circadian measures can predict future alcohol use in adults.”
zurity Pharmaceuticals, Inc. has issued a voluntary recall of 1 lot of Zenzedi CII 30 mg tablets after a Nebraska pharmacist discovered carbinoxamine maleate, an antihistamine, in a bottle labeled as Zenzedi 30 mg.
zurity Pharmaceuticals, Inc. has issued a voluntary recall of 1 lot of Zenzedi CII 30 mg tablets after a Nebraska pharmacist discovered carbinoxamine maleate, an antihistamine, in a bottle labeled as Zenzedi 30 mg.
A genetic predisposition to sleeping fewer than 5 hours a night was strongly associated with depression onset over an average 8 years of follow-up in adults 50 years and older, according to a study published in Translational Psychiatry.
A genetic predisposition to sleeping fewer than 5 hours a night was strongly associated with depression onset over an average 8 years of follow-up in adults 50 years and older, according to a study published in Translational Psychiatry.
Hitting the snooze button for 30 minutes in the morning slightly improved or did not affect cognitive performance upon waking in habitual snoozers, according to research published in the Journal of Sleep Research.
Hitting the snooze button for 30 minutes in the morning slightly improved or did not affect cognitive performance upon waking in habitual snoozers, according to research published in the Journal of Sleep Research.
Just 3 months of home-based transcutaneous electrical stimulation improved obstructive sleep apnea (OSA) severity and sleepiness in patients with low adherence to continuous positive airway pressure (CPAP) therapy.
Just 3 months of home-based transcutaneous electrical stimulation improved obstructive sleep apnea (OSA) severity and sleepiness in patients with low adherence to continuous positive airway pressure (CPAP) therapy.
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP).
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP).
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine.
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
To view accreditation information/faculty disclosures for the program, click
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
To view accreditation information/faculty disclosures for the program, click
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
To view accreditation information/faculty disclosures for the program, click
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
To view accreditation information/faculty disclosures for the program, click
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
To view accreditation information/faculty disclosures for the program, click
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
To view accreditation information/faculty disclosures for the program, click
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
To view accreditation information/faculty disclosures for the program, click
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
To view accreditation information/faculty disclosures for the program, click